drugset / Trial / NCT07483671

Efficacy and Safety Study of BPR-101 Capsules in Combination With Metronidazole in BV Patients

NCT07483671 ↗

Phase 2 Not yet recruiting 80 enrolled Chengdu Syncor Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

This trial employed a multicenter, randomized, double-blind, parallel, placebo-controlled design to evaluate the preventive effect of BPR-101 capsules combined with metronidazole on the recurrence of BV, as well as the cure rate and safety.

Timeline

Start
2026-04-15
Primary completion
2027-01-24
Completion
2027-01-24

Drugs

EvaluationDrugModalityDoseRoute
Subject BPR-101 Unknown — Other

Indications